Ebv and HHV-6 Circulating Subtypes in People Living With Hiv in Burkina Faso, Impact on Cd4 T Cell Count and Hiv Viral Load

Traoré, Lassina; Nikiema, Ouéogo; Ouattara, Abdoul Karim; Compaoré, Tegwinde Rebeca; Soubeïga, Serge Théophile; Diarra, Birama; Obiri‐Yeboah, Dorcas; Sorgho, Pegdwendé Abel; Djigma, Florencia Wendkuuni; Bisseyé, Cyrille; Yonli, Albert Théophane; Simporé, Jacques

doi:10.4084/mjhid.2017.049

Cited by 10 publications

(7 citation statements)

References 51 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, there was significant predominance of males among infected children. Similar results were reported from previous study from Burkina Faso with more prevalence of EBV and HHV6 in male patients below 5 years [34] .…”

Section: Primers and Probes Sequences Virussupporting

confidence: 91%

Study of Epstein Barr virus, Human Herpes 6 and Human Herpes 7 in Children with Acute Lymphoblastic Leukemia

Rizk¹,

Darwish²

2019

Int.J.Curr.Microbiol.App.Sci

View full text Add to dashboard Cite

Section: Primers and Probes Sequences Virussupporting

confidence: 91%

Study of Epstein Barr virus, Human Herpes 6 and Human Herpes 7 in Children with Acute Lymphoblastic Leukemia

Rizk¹,

Darwish²

2019

Int.J.Curr.Microbiol.App.Sci

View full text Add to dashboard Cite

“…We also show that the risk of HIV/EBV-1/2 multiple infection was higher in patients with longer HIV-1 infection, which emphasizes our warning because coinfections are common in patients who start treatment late, have the highest associated risk rate, and are also correlated with advanced clinical disease stages 117 , 118 . For EBV, this becomes more specific because the prevalence of EBV-1 and of multiple infection predominate in the most immunosuppressed patients; however, it is not known which factors may be involved in this scenario 44 , 119 .…”

Section: Discussionmentioning

confidence: 99%

Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region

Pereira

França

Costa

et al. 2021

Sci Rep

View full text Add to dashboard Cite

To identify the prevalence and risk factors for primary Epstein–Barr virus (EBV) infection in human immunodeficiency virus (HIV)-1-positive adult treatment-naïve patients between January 2018 and December 2019 in a state of the Brazilian Amazon region. A total of 268 HIV-1 positive patients and 65 blood donors participated in the study. Epidemiological data were obtained from medical records and through a designed questionnaire. EBV infection was screened by the semiquantitative detection of anti-viral capsid antigen (VCA) EBV IgM and IgG, followed by molecular detection of the EBNA-3C gene. The plasma viral loads of HIV-1 and EBV were quantified using a commercial kit. The prevalence of primary coinfection was 7.12%. The associated risk factors were education level, family income, history of illicit drug use and sexually transmitted infections, homosexual contact and condom nonuse. Approximately 58.5% had late initiation of highly active antiretroviral therapy, which influenced the risk of HIV-EBV 1/2 multiple infection (odds ratio (OR): 4.76; 95% CI 1.51–15.04) and symptom development (p = 0.004). HIV viral load was associated with patient age (OR: 2.04; 95% CI 2.01–2.07; p = 0.026) and duration of illicit drug use (OR: 1.57; 95% CI 1.12–2.22; p = 0.0548). EBV viral load was associated with younger age (OR: 0.82; 95% CI 0.79–1.03; p = 0.0579). The replication of both viruses was associated with symptom development (HIV = OR: 2.06; 95% CI 1.22–3.50; p = 0.0073; EBV = OR: 8.81; 95% CI 1–10; p = 0.0447). The prevalence of HIV/EBV coinfection was lower than that observed in other studies, and social vulnerability and promiscuous sexual behavior were associated risk factors. A long time of HIV-1 infection, without therapy, influenced the risk of coinfection and disease progression. The viral loads of both viruses may be associated with some epidemiological aspects of the population.

show abstract

“…HIV-positive patients on a highly active antiretroviral treatment would not act on a herpes virus infection but could prevent the reactivation of these viruses. 21 In an EBV infection, HAART treatment to improve CD4+ T cell restoration while contributing to lower HIV viral load does not affect. 22 A herpesvirus infection is more likely to be found in HAART patients with high CD4 T cell counts.…”

Section: Discussionmentioning

confidence: 99%

<p>First Report on HHV-6 Infection Among HIV-Infected Individuals Residing in Surabaya, Indonesia</p>

Oktafiani¹,

Megasari²,

Ana³

et al. 2020

HIV

View full text Add to dashboard Cite

Background: Morbidity and mortality from acquired immunodeficiency syndrome (AIDS) are often associated with the reactivation of a herpes virus infection. Human herpesvirus-6 (HHV-6) is usually common in childhood infections that remain latent and can act as opportunists during immunosuppression to reactivate and cause disease. In human immunodeficiency virus (HIV)-infected patients, the impact of HHV-6 infection can be an upregulator of HIV replication and accelerate progress towards AIDS. However, studies on HHV-6 infection have never been done in Surabaya, Indonesia. Purpose: To determine the presence of HHV-6 infection among HIV-infected individuals residing in Surabaya, Indonesia. Patients and Methods: Plasma and peripheral blood mononuclear cells (PBMCs) were collected from 85 HIV-infected individuals in Universitas Airlangga Hospital, Surabaya, as well as 85 healthy controls. DNA extracted from PBMCs was subjected to PCR to determine HHV-6 infection, while plasma of HIV-infected individuals was used for viral RNA quantification using real-time PCR. Results: HHV-6 infection was detected in 17.6% (15/85) of HIV-infected individuals, and in 3.53% (3/85) of healthy controls. Thus, HHV-6 infection was more likely to be found in HIVinfected individuals than in healthy controls (odds ratio 5.85; 95% confidence interval, 1.6-21). The HHV-6B was the most common subtype identified in both HIV-infected individuals (12/15) and healthy controls (3/3). The HHV-6A and co-infection between HHV-6A and HHV-6B were only found in HIV-infected individuals (2/15 and 1/15, respectively). Viral RNA load of HIV-infected individuals was not correlated to HHV-6 infection. Conclusion: Our results indicate the emergence of HHV-6 infection among HIV-infected individuals residing in Surabaya, Indonesia, and the risk of HHV-6 infection was higher in HIV-infected individuals than in healthy controls.

show abstract

Ebv and HHV-6 Circulating Subtypes in People Living With Hiv in Burkina Faso, Impact on Cd4 T Cell Count and Hiv Viral Load

Cited by 10 publications

References 51 publications

Study of Epstein Barr virus, Human Herpes 6 and Human Herpes 7 in Children with Acute Lymphoblastic Leukemia

Study of Epstein Barr virus, Human Herpes 6 and Human Herpes 7 in Children with Acute Lymphoblastic Leukemia

Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region

<p>First Report on HHV-6 Infection Among HIV-Infected Individuals Residing in Surabaya, Indonesia</p>

Contact Info

Product

Resources

About